Published in MD Week, November 24th, 2006
According to a study from the United States, "Prostaglandin E-2 plays a growth-stimulatory role in breast cancer, and the rate-limiting enzyme in its synthesis, cyclooxygenase-2, is often overexpressed in these cancers. Little is known about the role of the key prostaglandin catabolic enzyme 15-PGDH in breast cancer pathogenesis."
"Using a pharmacologically based screen for epigenetically silenced genes, we found low levels of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week